Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ4N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,431
Award facts
- Contract value 100% obligated
- $28,431.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 20, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $28,431.20 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by January 21, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, operating as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen).
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as the primary vehicle enabling the company to supply a broad range of pharmaceutical products, medical supplies, and specialty medications to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems. REPATHA is a cholesterol-lowering medication used in cardiovascular treatment, reflecting the contractor's extensive portfolio in specialty pharmaceutical delivery across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FJJ4N?
SPE2DR26FJJ4N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FJJ4N worth?
The government has obligated $28,431 on SPE2DR26FJJ4N.
Is contract SPE2DR26FJJ4N an order under another contract?
Yes. SPE2DR26FJJ4N is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ4N competed?
The extent of competition for SPE2DR26FJJ4N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award